DiaMedica Therapeutics annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
DiaMedica Therapeutics Operating Expenses Growth & History (DMAC)
DiaMedica Therapeutics's operating expenses was $34.4M for fiscal 2025.
View full DiaMedica Therapeutics company overviewDiaMedica Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $34.4M | $7.7M | +28.92% |
| 2024 | 2024-12-31 | $26.7M | $5.4M | +25.46% |
| 2023 | 2023-12-31 | $21.3M | $7.3M | +51.90% |
| 2022 | 2022-12-31 | $14.0M | $355,000 | +2.60% |
| 2021 | 2021-12-31 | $13.6M | $947,000 | +7.46% |
| 2020 | 2020-12-31 | $12.7M | $1.1M | +9.54% |
| 2019 | 2019-12-31 | $11.6M | $4.3M | +59.66% |
| 2018 | 2018-12-31 | $7.3M | $2.7M | +60.68% |
| 2017 | 2017-12-31 | $4.5M | — | — |
DiaMedica Therapeutics quarterly operating expenses
Q1.18
Q1.19
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $10.5M | $2.5M | +31.11% |
| Q1 2026 | 2026-03-31 | $10.5M | $2.3M | +28.71% |
| Q4 2025 | 2025-12-31 | $9.2M | — | — |
| Q3 2025 | 2025-09-30 | $9.0M | — | — |
| Q2 2025 | 2025-06-30 | $8.0M | — | — |
| Q1 2025 | 2025-03-31 | $8.1M | — | — |
| Q1 2019 | 2019-03-31 | $3.4M | $2.1M | +161.94% |
| Q1 2018 | 2018-03-31 | $1.3M | — | — |
DiaMedica Therapeutics operating expenses trends
Over the last five fiscal years, DiaMedica Therapeutics's operating expenses increased from $12.7M to $34.4M, a change of $21.7M. The latest reported quarter, Q2 2026, shows $10.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review DiaMedica Therapeutics source filings ↗